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Abstract
Liposomes have been used therapeutically and as a local drug delivery system in the blad-
der. However, the exact mechanism for the uptake of liposomes by bladder cells is unclear.
In the present study, we investigated the role of endocytosis in the uptake of liposomes by
cultured human UROtsa cells of urothelium and rat bladder. UROtsa cells were incubated in
serum-free media with liposomes containing colloidal gold particles for 2 h either at 37°C or
at 4°C. Transmission Electron Microscopy (TEM) images of cells incubated at 37°C found
endocytic vesicles containing gold inside the cells. In contrast, only extracellular binding
was noticed in cells incubated with liposomes at 4°C. Absence of liposome internalization at
4°C indicates the need of energy dependent endocytosis as the primary mechanism of
entry of liposomes into the urothelium. Flow cytometry analysis revealed that the uptake of
liposomes at 37°C occurs via clathrin mediated endocytosis. Based on these observations,
we propose that clathrin mediated endocytosis is the main route of entry for liposomes into
the urothelial layer of the bladder and the findings here support the usefulness of liposomes
in intravesical drug delivery.
Introduction
Intravesical therapy is the routine first-line treatment for effectively delaying or preventing the
recurrence of bladder cancer [1]. This route of drug administration has also shown tremendous
promise in the treatment of interstitial cystitis/painful bladder syndrome (IC/PBS) [2] and
overactive bladder [3] to justify investments for further improvements [4]. Intravescial route of
drug administration is preferred in conditions which are refractory to conventional treatment
by oral route. Orally administered agents are often unable to create effective luminal drug con-
centration due to low urinary excretion of drugs, which justifies bladder instillation [5].
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Replacement of glycosaminoglycan (GAG) layer by intravesical administration of hyaluronic
acid has been successfully tried in IC/PBS [6].
The urinary bladder has evolved to form an effective epithelial barrier to hold urine which
carries toxic substances. The barrier function exerted by the epithelium of urinary bladder
(urothelium) has typical umbrella cells attached by tight junction proteins and concealed by im-
penetrable plaques and anti-adherent mucin layer. Low permeability of the urothelium limits
the penetration of the instilled drug across the urothelium [7] which allows administration of
agents that may be too toxic for systemic administration. Direct instillation or cystoscope guided
injection of potentially toxic drugs such as botulinumtoxin or resiniferatoxin in the bladder can
achieve maximal therapeutic benefit at the target site without systemic toxicity [8]. Several
drugs including lidocaine, heparin, dimethyl sulfoxide, chondroitin sulfate, hyaluronic acid have
been shown to demonstrate benefit for lower urinary tract symptoms (LUTS) via intravesical
route, but a similar benefit in LUTS is not derived from their systemic administration.
Intravesical therapy also holds the potential to facilitate the separation of therapeutic effect
from side-effects by involving a diverse array of novel chemical, pharmacological, and formula-
tion strategies. However, drug delivery by intravesical route is constrained by the impermeabil-
ity of the urothelium and the need for frequent administration. Instilled drug solutions become
diluted with urine and get washed out of the bladder during voiding, necessitating repeated in-
fusions of the drug. Therefore, there is ongoing search for drug delivery methods to improve
intravesical drug delivery [9].
Of all the drug delivery platforms, liposomes have been approved by US Food and Drug Ad-
ministration for the safe and effective delivery of several drugs [10]. In recent years, empty lipo-
somes have been instilled as a potential therapy for interstitial cystitis [11,12]. Liposomes have
vesicular structures consisting of an aqueous core surrounded by a lipid bilayer [13], which
allow delivery of both lipophilic drugs such as capsaicin and hydrophilic drugs such as botuli-
num toxin. The therapeutic advantage derived from use of liposomes as a drug carrier has been
previously demonstrated in human and animal studies [1,9,11,12]. However, the exact cellular
mechanism underlying liposome uptake by bladder remained unclear. Endocytosis pathway
was shown to be a possible major contributor to the cellular uptake of liposomes [1]. Hence we
investigated the possible role of endocytosis in the uptake of liposomes by urothelium.
Materials and Methods
Materials
Dulbecco’s Modified Eagle Medium (DMEM) was obtained from GIBCO, BRL (Carlsbad, CA,
USA). N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl] (NBD) was purchased
from Avanti Polar Lipids (Birmingham, AL, USA). The chemicals Annexin V Apoptosis detec-
tion (AAD), Methyl-β-cyclodextrin (mhCD), Chlorpromazine (CPZ) and Dithionite were ob-
tained from Sigma Aldrich, St. Louis. Phosphate-buffered saline (PBS) was purchased from
Fisher Scientific. Normal human urothelium UROtsa cells were kindly provided by Dr. Scott
Garrett (University of North Dakota, USA) and cultured in DMEM (Gibco) without phenol
red [14].
Preparation of liposomes
50 mg of lipids obtained from Avanti Polar was dissolved in a chloroform methanol mixture
(3:1) which was dried into a thin film inside walls of a round bottom flask using steady stream
of nitrogen. The round bottom flask with lipid was kept overnight under vacuum to remove
any traces of organic solvent. Then 5 mL of colloidal gold nanoparticle (10 nm) was added to
hydrate the dried lipid followed by vortex and sonication at 65°C. The round bottom flask was
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kept at -80°C for 1 h and thawed using ice for 30 min and again vortexed and sonicated at
65°C. The freeze thaw cycle was repeated 3 times to procure the liposome encapsulated gold,
which was centrifuged at 2000rpm for 5 min and pellet resuspended in sterile water for use in
both in vitro and in vivo studies for TEM. The final lipid concentration of liposomes in the ex-
periments was similar that used in studies employing liposomes as a carrier for botulinum
toxin [15].
In vitro urothelium cell uptake study
UROtsa cells (1x105) were plated in 100 mm petridishes and grown for 2 days in Dulbecco’s
modified Eagle’s medium (DMEM) containing 5% v/v fetal bovine serum at 37°C in 5% CO2
atmosphere. Cells were incubated with or without liposomes in serum free DMEMmedia for
2 h either at 37°C or at 4°C. After 2 h incubation, cells were washed with plain media and sub-
jected for TEM study.
In vivo bladder uptake study
This study was carried out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was ap-
proved by the Beaumont Research Institute (Royal Oak, MI, USA) Animal Care Committee
(IACUC approval number: AL-12-07). Female Sprague Dawley rats were procured from
Charles River Laboratories, MA. Rats were divided into 2 groups; group 1 instilled with empty
liposomes (n = 4) and group 2 treated with liposomes encapsulated gold (lipo-gold) (n = 4).
Under isoflurane anesthesia, rat bladder was emptied of urine, and then a catheter was inserted
through the urethra and instilled with 0.5 mL of liposome or lipo-gold into the bladder for
30 min. After instillation, animals were allowed to recover and returned to their cages. Animals
were sacrificed 8 h after instillation by administering sodium pentobarbitone 120 mg/kg. Rat
bladders were washed with normal saline, filled with 0.5 mL of fixative solution (1% osmium
tetroxide in 0.1 M cacodylate), harvested and then placed in fixative solution for TEM study.
TEM Study
UROtsa cells and bladder specimens were rinsed with 0.2M Cacodylate pH 7.4 for 5 min and
fixed with 2% glutaraldehyde in 0.1M Cacodylate. Specimens were post fixed using 1% osmium
tetroxide in 0.1M cacodylate for 1 h at 4°C. Fixed specimens were given a wash with 7% sucrose
overnight and dehydrated for 15 min at graded concentrations (50, 70, 90 & 100%) of ethanol
and then incubated in propylene oxide for 10 min followed by infiltration of specimen with 1:1
(propylene oxide:812 epoxy resin) for 1 h. Subsequent steps involved embedding in block and
polymerization at 60°C overnight. Ultra-thin sections were cut with Ultra-microtome RMC
MT-7000, Tucson, AZ, which was negatively stained with uranyl acetate with silver enhancer.
Images were acquired using Morgagni 268 Transmission Electron Microscope FEI Company,
Hillsboro, OR.
Flow cytometry
UROtsa cells were seeded in 6-well plates (1x105) for approximately 2–3 days to achieve 70%
confluency. Cells were incubated in phenol red free DMEM with liposomes containing fluores-
cent label NBD for 60 min. After incubation, cells were washed once with 2 mL PBS, collected
by trypsinisation, pelleted, washed once in 1 mL PBS and resuspended in 0.3 mL PBS. The cell
suspension was analyzed within 30 min. In the case of NBD-labeled liposomes, an intermediate
step prior to trypsinization was done. This involved addition of 50 μL of a 1.5M dithionite
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solution to the cells for 5 min and the cells were washed 3X with PBS. For blocking experi-
ments, cells were incubated with the inhibitors Chlorpromazine (CPZ) (inhibitor of clathrin
mediated endocytosis) and Methyl-β-cyclodextrin (mhCD) (inhibitor of caveolae mediated en-
docytosis) prior to incubation with liposomes.
Flow cytometric analysis for fluorescent signal from liposomes was performed using a
4-color FACS-Calibur (Becton Dickinson, Heidelberg, Germany) equipped with an argon laser
exciting at a wavelength of 488 nm. For each sample, 10000 events were collected by list-mode
data that consisted of side scatter, forward scatter and fluorescence emission centered at
530 nm (FL1) and 585 nm (FL2), respectively. For 7-Annexin V Apoptosis detection (AAD), a
long-pass filter with a cutoff of 670 nm (FL3) was applied. The fluorescence was collected on a
logarithmic scale with a 1024 channel resolution. Cell Quest Pro software (Becton Dickinson,
Heidelberg, Germany) was applied for the analyses.
Statistical analysis
Statistical analysis was performed using GraphPad Prism, 4.03 (San Diego). One way analysis
of variance (ANOVA) followed by Dunnett’s post hoc used for other parameters. Data was ex-
pressed in means ± S.E.M. P< 0.05 was fixed as the statistical significance criterion.
Results
In vitro study
Ultrastructural studies of UROtsa cells showed that cells lie adjacent to one another in a mono-
layer arrangement and are connected to one another with finger like projections called as later-
al interdigitation (LI). The size of nucleus in UROtsa cell is comparatively larger with higher
nuclear to cytoplasmic ratio. UROtsa cells incubated with colloidal gold particles in absence of
liposomes did not internalize any of the gold particles as indicated by dark grains lying outside
the cell on EM image representing gold particles (G) (Fig. 1). Compared to faint to dark grey
color of uranyl acetate staining acquired by other cell organelles, the electron dense gold parti-
cles appear as dark grains. Inscribed area in panel A and B is magnified 3 times further in panel
C and D, respectively to show a single cell. The cellular uptake of gold particles was not affected
by temperature as evident from the EM images of cells taken after incubation at 37°C (Panel
A&C) or at 4°C (Panel B&D) for 2 h.
In contrast, EM images of UROtsa cells incubated with liposomes encapsulating gold parti-
cles at 37°C showed cluster of dark gold particles inside the cell and not outside the cell mem-
brane (Fig. 2A). Corresponding higher magnification of the image showed that dark grains of
gold were associated with vesicle like structures in an endosomal compartment (E) of UROtsa
cells (Fig. 2C). Incubation of UROtsa cells with liposomes encapsulating gold particles at 4°C
showed absence of dark grains inside the cell and only extracellular binding of liposomes con-
taining dark grains of gold was seen (Fig. 2B). Corresponding higher magnification in Panel D
showed that vesicle like structures were devoid of dark gold particles indicating absence of in-
ternalization and the temperature dependence for the cellular uptake of encapsulated gold par-
ticles. Since temperature had no effect on the internalization of gold particles (Fig. 1), it can be
inferred that liposomes as a carrier is necessary for the endocytosis to occur.
In vivo study
Rat bladder was instilled with encapsulated liposome showed the uptake of gold across the
urothelium (Fig. 3A); whereas the bladder instilled with plain gold showed the gold particles
lying outside the tissue region of sections (Fig. 3B). The untreated bladder is shown as control
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image (Fig. 3C). The results support the evidence regarding the endocytosis of liposomes in
bladder [1].
Flow Cytometry
The different endocytosis mechanisms operational in liposome uptake were studied with the
help of different inhibitors. In this study, we used a series of pharmacological inhibitors: CPZ
concentration range from 14 to 28 μM and mhCD concentration range from 6 to 9 mM to in-
hibit clathrin and caveole mediated endocytosis, respectively. Pre incubation of UROtsa cells
with CPZ for 60 min caused partial blockade of fluorescent liposome uptake at 24 μM and
complete blockade at 28 μM. As shown by flow cytometric analysis, the uptake of liposomes in
UROtsa cells was also reduced by 50% after a preincubation period of 60 min with mhCD
(Fig. 4), but complete blockade was not achieved as increased cell death limited the options of
using a higher concentrations of mhCD or longer preincubation times.
Fig 1. TEMmicrographs of UROtsa cells demonstrate the lack of any internalization of colloidal gold
particles in absence of liposomes by absence of any dark grains inside the cells. Compared to faint to
dark grey color of uranyl acetate staining acquired by other cell organelles and electron dense gold particles
appear as dark grains. UROtsa cells incubated at either 37°C (Panel A&C) or at 4°C (Panel B&D) showed
similar absence of any dark grains inside the endosome marked by E in all the panels to indicate uptake was
independent of temperature. Inscribed area of panel A and B in white rectangle is magnified 3 times further in
panel C and D, respectively. UROtsa cells have prominent large nucleus shown by N and cells are marked by
finger like projections called lateral interdigitation (shown by LI) for connecting with adjacent cells. Plain gold
is marked by red colored G, Magnification is shown by the scale bar in each panel.
doi:10.1371/journal.pone.0122766.g001
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Discussion
In the present study, the endocytosis mechanism of liposome uptake was carefully studied by
functional and ultrastructural studies performed on urothelium cell line. Earlier studies using
liposomes constituted with uptake tracking molecules indicated possible involvement of endo-
cytosis in the cellular uptake of the liposomes [16]. Liposomes have been widely used as drug
carriers for systemic administration of chemotherapeutic agents [17,18] to achieve the outcome
of improved pharmacokinetics and reduced toxicity [18–20]. The success of liposomes in the
clinic has been attributed to the nontoxic nature of the lipids used in their formulation. Previ-
ous studies from our group have reported that incorporation of tacrolimus into liposomes can
be developed as an effective treatment for hemorrhagic cystitis [11]. Liposomes improved the
pharmacokinetics of liposomal tacrolimus by maintaining higher drug concentration inside
the bladder tissue compared to the plain tacrolimus [21]. However, the mechanism of bladder
uptake for instilled liposomes was unclear.
Fig 2. TEMmicrographs showing endocytosis mediated uptake of liposome encapsulated gold
marker at 37°C (Panel A&C). Higher magnification image of inscribed area from panel A showed that vesicle
like structures in endosomal compartment (marked by E) contained cluster of electron dense dark particles
inside a single cell (Panel C). In contrast, only extracellular binding of liposomes containing dark grains was
observed at 4°C (Panel B) and corresponding higher magnification image (Panel D) showed that vesicle like
structures in a single cell were devoid of dark gold particles, which indicates absence of internalization due to
temperature dependent inhibition of endocytosis. Gold encapsulated in liposomes is marked by red colored G
inside a red circle, nucleus is marked by N, endocytic vesicles are marked by E and finger like projections
called as lateral interdigitation are marked by LI. Inscribed area of panel A and B in white rectangle is
magnified further in panel C and D, respectively and magnification is shown by scale bar in each panel.
doi:10.1371/journal.pone.0122766.g002
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Absence of liposome internalization at 4°C in TEM images indicates the need of energy de-
pendent endocytosis as the primary mechanism of entry for liposomes into urothelium.
UROtsa cells incubated with liposome at 37°C showed endocytic vesicles containing liposomes
as indicated by electron dense gold particles appearing as dark grains. Images suggest that
upon binding of liposomes with cell membrane, the endocytic internalization of lipo-gold
would have occurred and then released from the endosomal vesicles [22] (Fig. 5). The lipo-
somes wrapped by the endosomal membrane get destabilized due to intermingling of lamellar
phase-perturbing lipids with the endosomal membrane [23]. Findings obtained at 4°C are con-
sistent with decreased ability of liposomes composed of non-ionic lipids to fuse with endocytic
vesicles at this temperature [22]. Findings from cellular experiments were reproduced in rat
bladder, where TEM images of rat bladder 8 h after instillation of lipo-gold showed several
gold grains inside the urothelium. Intracellular gold was missing in rat instilled with plain gold.
Findings suggest that bladder uptake of liposomes involved endocytosis. From this, it is evident
that the transport of drugs (represented by colloidal gold) instilled in the bladder is dependent
upon the pathway of entry preferred by carrier over mechanism preferred by the encapsulated
drugs in the liposomes [24] (Fig. 5).
Several aspects of internalization regarding different forms of endocytosis involved in lipo-
some uptake are illustrated in Fig. 5. It is accepted that all forms of endocytosis, whether depen-
dent or independent of caveolin or clathrin mediated pathways do require energy, which
therefore explains the inhibition of liposome uptake by cells incubated at 4°C. Complete
Fig 3. TEMmicrographs showing endocytosis mediated uptake of liposome encapsulated gold in rat
bladder (A) as revealed by electron dense dark grains consistent with uptake of gold across the
urothelium. (B) Dense black grains binding to the cell surface were noted in rat group instilled with colloidal
gold in absence of liposomes. Gold encapsulated in liposomes are marked by red colored G inside a red
circle and plain gold is marked by yellow G in the images. (C) Untreated rat bladder is marked by (absence of
dark black gold grains. Magnification of 8900x was used in all the images and is shown by the scale bar.
doi:10.1371/journal.pone.0122766.g003
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blockade of fluorescent liposome uptake by CPZ suggests that UROtsa cells internalize lipo-
somes via clathrin mediated endocytosis. CPZ interacts with clathrin of the coated pits and
causes their loss from the surface membrane, which therefore makes CPZ an important tool
for studying clathrin mediated endocytosis [25]. Preincubation with CPZ caused a dose depen-
dent inhibition of fluorescent liposome uptake by UROtsa cells, which suggests the preponder-
ance of clathrin mediated endocytosis in internalization of liposomes by UROtsa cells.
Predominance of clathrin mediated endocytosis of liposomes is also consistent with the accu-
mulation of dark gold grains in the subcellular organelle of endosome in the TEM images.
Fig 4. Effect of different endocytic inhibitors on cellular uptake of fluorescent liposomes. Flow
cytometry analysis suggest clathrin mediated endocytosis as the dominant pathway for the internalization of
fluorescently labeled liposomes by UROtsa cells at 37°C. Chlorpromazine (inhibitor of clathrin) dose
dependently inhibited the internalization as cell fluorescence from externally bound non-internalized
liposomes was quenched by sodium dithionite. Fluorescence intensity of liposomes in cells untreated with
inhibitors was taken as 100%.
doi:10.1371/journal.pone.0122766.g004
Fig 5. Illustration depict temperature dependent endocytoic uptake of liposome encapsulated gold
(Lipo-gold). The cellular process of clathrin and caveolin mediated endocytosis are energy dependent and
therefore only occur at 37°C and are inhibited at 4°C. Compared to mhCD, chlorpomazine was more efficient
in blocking endocytosis of liposomes, which indicates a predominance of clathrin mediated endocytosis as a
mechanism of endocytosis.
doi:10.1371/journal.pone.0122766.g005
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Interestingly, a role for caveolar endocytosis was previously reported in the liposome uptake
of cultured HeLa cells [16] and therefore, we also presumed a role for caveolar endocytosis in
liposome uptake by UROtsa cells as illustrated in Fig. 5. We used water soluble mhCD for in-
hibiting caveolae mediated endocytosis, as it has been used in other published studies [26,27].
In our experiments, mhCD only partially blocked the fluorescent liposome uptake by UROtsa
cells, which suggest that caveolin mediated endocytosis was less dominant than clathrin medi-
ated endocytosis for liposomes. Moreover, it is known that mhCD forms soluble inclusion
complexes with cholesterol and depletes cholesterol from the plasma membrane, which can
compromise cholesterol rich microdomains involved in both caveolae as well as clathrin medi-
ated endocytosis. This effect of mhCD on membrane structure may in part explain the absence
of a dose dependent inhibition of fluorescence uptake seen in cell preincubated with mhCD.
The FACS analysis and accumulation of liposomes encapsulated gold in endosome (TEM im-
ages) together support the dominance of clathrin mediated endocytosis over caveolar endocy-
tosis for liposomes in UROtsa cells.
As shown in Fig. 5, UROtsa cells may employ several diverse energy dependent processes in
parallel for liposome uptake. Based on published reports, one or other process may dominate
depending on attributes of liposomes and cells tested. In conclusion, the findings of our study
demonstrate in vitro and in vivo evidence for endocytosis as the mechanism of liposome uptake
in bladder.
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